Robert Hershberg sold $496k of ATAI
director at AtaiBeckley Inc.. 100,000 shares at an average of $4.96, traded Jul 7, 2026, filed Jul 9, 2026.
Score components
- +15RoleDirector
- +18Trade size$496k at market
- +20Share of holdings soldSold 50% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-028137, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | MOption exercise Common Stock10b5-1 | +48,858 | $1.35 | $66k | 48,858 | Jul 9, 2026 |
| Jul 7, 2026 | MOption exercise Common Stock10b5-1 | +51,142 | $1.35 | $69k | 100,000 | Jul 9, 2026 |
| Jul 7, 2026 | SOpen-market sale Common Stock10b5-1 | -100,000 | $4.96 | $496k | 100,000 | Jul 9, 2026 |
| Jul 7, 2026 | MOption exercise Stock Optionderivative10b5-1 | -48,858 | $0.00 | $0 | 48,858 | Jul 9, 2026 |
| Jul 7, 2026 | MOption exercise Stock Optionderivative10b5-1 | -51,142 | $0.00 | $0 | 404,869 | Jul 9, 2026 |
Related signals
Other insiders at AtaiBeckley Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | AtaiBeckley Inc. | Gerd Kochendoerfer Chief Operating Officer | $250k 50,000 shares | -100% | |
| 27Weak | AtaiBeckley Inc. | Kevin James Craig Chief Medical Officer | $192k 42,579 shares | -83% | |
| 12Weak | AtaiBeckley Inc. | Kevin James Craig Chief Medical Officer | $213k 42,579 shares | -83% | |
| 15Weak | AtaiBeckley Inc. | Kevin James Craig Chief Medical Officer | $355k 100,000 shares | -92% | |
| 26Weak | ATAIsell AtaiBeckley Inc. | Cosmo Feilding-Mellen director | $154k 39,594 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.